Earnings Call Summary | NCS Multistage(NCSM.US) Q4 2023 Earnings Conference
Earnings Call Summary | NCS Multistage(NCSM.US) Q4 2023 Earnings Conference
The following is a summary of the NCS Multistage Holdings, Inc. (NCSM) Q4 2023 Earnings Call Transcript:
以下是 NCS Multistage Holdings, Inc. (NCSM) 2023年第四季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
NCS Multistage Holdings reported a Q4 revenue of $35.2 million, marking a decline of 12% from last year's fourth quarter. U.S. and international revenues saw a decrease of 33% and 40% respectively. However, the net income for Q4 2023 was significantly higher at $39.6 million due to the settlement of a legal matter that required no cash payment.
Total revenue for 2023 was $142.5 million, a decrease of 8% compared to the previous year. However, a free cash flow of $2.6 million for 2023 and a strong beginning balance of almost $17 million for 2024 suggests the company's finances are stable.
The company projects Q1 2024 revenues to be between $36 million to $40 million, with an improved adjusted gross margin of 38% to 41%.
NCS Multistage Holdings公佈的第四季度收入爲3520萬美元，比去年第四季度下降了12％。美國和國際收入分別下降了33％和40％。但是，2023年第四季度的淨收入大幅增加，達到3,960萬美元，這是由於一項無需現金支付的法律問題得以解決。
2023年的總收入爲1.425億美元，與上年相比下降了8％。但是，2023年260萬澳元的自由現金流和2024年近1700萬美元的強勁期初餘額表明該公司的財務狀況穩定。
該公司預計，2024年第一季度的收入將在3,600萬美元至4000萬美元之間，調整後的毛利率將提高38％至41％。
Business Progress:
業務進展：
NCS Multistage anticipates growth in 2024 from new markets and alignment with large independent customers despite a projected decline in industry activity.
After successfully consolidating certain U.S. operations districts and manufacturing facilities, the company is well-positioned for the deepwater market.
The company expects expansion in tracer diagnostics business in the Middle East.
Development on the pinpoint internally oriented perforating gun system, expansion of the airlock casing buoyancy systems and the introduction of the SlimStim refrac liner hanger system are anticipated in 2024.
The company aims to generate free cash flow and improve its adjusted EBITDA margin in 2024, despite the past legal disputes.
儘管預計行業活動將下降，但NCS Multistage預計，2024年新市場將實現增長，並與大型獨立客戶保持一致。
在成功整合了某些美國運營區域和製造設施之後，該公司爲深水市場做好了充分的準備。
該公司預計，在中東的示蹤劑診斷業務將擴大。
預計將在2024年開發精確定位內部定向穿孔槍系統、擴展氣閘外殼浮力系統以及推出SlimStim refrac 襯裏懸掛系統。
儘管過去存在法律糾紛，但該公司的目標是在2024年創造自由現金流並提高調整後的息稅折舊攤銷前利潤率。
More details: NCS Multistage IR
更多詳情： NCS 多級紅外
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。